▲
STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #1347 by analyst upside · 2026-09-28
RXST
RxSight, Inc.
Healthcare · Market Cap $194M · P/E 0x
ANALYST PRICE TARGET
+62.4%
implied upside to consensus target
Current Price $4.66
Consensus Target $7.57
Bull Target $11.0
Bear Target $5.5
Analysts Covering 8
ANALYST CONSENSUS - HOLD
Strong Buy
1
Buy
0
Hold
6
Sell
1
52-Week Low $4.48
52-Week High $13.22
YTD Return -55.1%
FUNDAMENTALS
Market Cap $194M
P/E Ratio (TTM) N/A
Forward P/E N/A
EPS (TTM) $-1.14
PEG Ratio N/A
Dividend Yield N/A
Revenue (TTM) $128M
Profit Margin -36.8%
52-WEEK RANGE
52-Week Low $4.48
52-Week High $13.22
Current Price $4.66
Bear Target $5.5
Bull Target $11.0
● Now $4.66 ● Target $7.57
TRADING DATA
Avg Volume 1.1M
YTD Return -55.1%
Analyst Count 8
Consensus Hold
Upside to Target +62.4%
Last Updated 2026-09-28

ANALYST SUMMARY

RxSight, Inc. (RXST) is currently trading at $4.66 with a Wall Street consensus price target of $7.57, implying potential upside of 62.4% over the next 12 months. 8 analysts currently cover RXST, with a consensus rating of Hold - 12% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $11.0, while the most cautious has a target of $5.5.

RXST operates in the Healthcare sector with a market capitalisation of $194M. The stock is down 55.1% year-to-date and is currently trading near the lower end of its 52-week range of $4.48 – $13.22.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

ORMP +48.0%
Oramed Pharmaceuticals Inc.
$197M · P/E 1.1x · Hold
CGEN +93.3%
Compugen Ltd.
$225M · P/E 6.3x · Buy
WW +97.4%
WW International, Inc.
$144M · P/E 1.6x · Hold
ELMD +74.0%
Electromed, Inc.
$233M · P/E 21.4x · Buy
PDEX +3.1%
Pro-Dex, Inc.
$230M · P/E 17.4x · Buy

RECENT ANALYST CALLS

Upgrade/downgrade history for RXST, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Jefferies - Reiterated
Hold → Hold 2026-09-22 50% win rate (6 calls)
B of A Securities - Reiterated
Underperform → Underperform 2026-09-22 Building track record
Stifel - Reiterated
Hold → Hold 2026-08-10 Building track record
UBS - Reiterated
Neutral → Neutral 2026-08-06 33% win rate (6 calls)
B of A Securities - Reiterated
Underperform → Underperform 2026-07-07 Building track record
Needham reit
Buy → Buy 2026-07-07 20% win rate (5 calls)
Wells Fargo - Reiterated
Equal-Weight → Equal-Weight 2026-05-07 Building track record
Needham - Reiterated
Buy → Buy 2026-05-07 20% win rate (5 calls)
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
25
out of 100
Coverage depth
17/30
Consensus clarity
6/30
Vote unanimity
0/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →